Search
Search
Close this search box.

Two New Legal Cannabis Dispensaries Approved in New York’s Upper East Side

Two more New York cannabis dispensaries have been granted the green light to open their doors as the state continues its battle against illicit stores.

Green Health LLC’s owner Anthony Melchior and Buffalo-based small business owner Deanna Brooks, who have both previously been granted licences to operate from the Office of Cannabis Management (OCM), can now move ahead with their plans to open dispensaries on the Upper East side.

According to Crain’s New York, the pair were given the go ahead from members of the Community Board 8s Street Life Committee last week.

Now the dispensaries have been approved, Mr Melchior is set to open a ‘luxury brand’ cannabis store in a vacant 800sq ft plot on East 81st Street.

Ms Brooks, who is a ‘justice involved applicant’ also plans to open a dispensary at 1707 Second Avenue, which is understood to currently be occupied by an incream shop.

The two new additions will join The Upper East Side’s only legal store The Herbal Care, which opened last month.

It comes amid growing tensions between the OCM and the state’s Governor Kathy Hochul, who doubled down on her criticism of the regulators roll out of licences last week.

During a budget discussion in Syracuse on Monday (February 05), Ms Hochul was asked whether the OCM’s leadership should be concerned about their jobs given the continued frustration from stakeholders about the snail’s pace of the licence roll out, which has enabled an illicit market to flourish.

She replied: “I’m not satisfied. I want more enforcement, I want to make sure that we are looking at leadership. I’m looking at opportunities to make major changes.”

Adding that the state’s 14 investors currently tasked with managing the issue was insufficient, Ms Hochul suggested local law enforcement could be given new powers to shut down unlicensed businesses.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?